J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 85 (2004), 1655-1663; DOI 10.1099/vir.0.79805-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacPhail, M.
Right arrow Articles by Haller, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacPhail, M.
Right arrow Articles by Haller, A. A.
Agricola
Right arrow Articles by MacPhail, M.
Right arrow Articles by Haller, A. A.
© 2004 Society for General Microbiology

Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design

Mia MacPhail1, Jeanne H. Schickli1, Roderick S. Tang1, Jasmine Kaur1, Christopher Robinson1, Ron A. M. Fouchier2, Albert D. M. E. Osterhaus2, Richard R. Spaete1 and Aurelia A. Haller1,{dagger}

1 MedImmune Vaccines Inc., 297 North Bernardo Avenue, Mountain View, CA 94043, USA
2 Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands

Correspondence
Aurelia A. Haller
aurelia.haller{at}globeimmune.com

Human metapneumovirus (hMPV), a recently identified paramyxovirus, is the causative agent of respiratory tract disease in young children. Epidemiological studies have established the presence of hMPV in retrospective as well as current clinical samples in Europe, USA, Canada, Hong Kong and Australia. The hMPV disease incidence rate varied from 7 to 12 %. This rate of disease attack places hMPV in severity between respiratory syncytial virus and human parainfluenza virus type 3, two common respiratory pathogens of young children, the elderly and immunosuppressed individuals. To evaluate the effectiveness and safety of future hMPV antiviral drugs, therapeutic and prophylactic monoclonal antibodies (mAbs), and vaccine candidates, it was necessary to identify small-animal and primate models that efficiently supported hMPV replication in the respiratory tract and produced neutralizing serum antibodies, commonly a clinical correlate of protection in humans. In this study, various rodents (mice, cotton rats, hamsters and ferrets) and two primate species, rhesus macaques and African green monkeys (AGMs), were evaluated for hMPV replication in the respiratory tract. The results showed that hamsters, ferrets and AGMs supported hMPV replication efficiently and produced high levels of hMPV-neutralizing antibody titres. Hamsters vaccinated with subgroup A hMPV were protected from challenge with subgroup A or subgroup B hMPV, which has implications for hMPV vaccine design. Although these animal models do not mimic human hMPV disease signs, they will nevertheless be invaluable for the future evaluation of hMPV antivirals, mAbs and vaccines.

{dagger}Present address: GlobeImmune Inc., Aurora, CO 80010, USA.




This article has been cited by other articles:


Home page
 J. Virol.Home page
M. Darniot, C. Pitoiset, T. Petrella, S. Aho, P. Pothier, and C. Manoha
Age-Associated Aggravation of Clinical Disease after Primary Metapneumovirus Infection of BALB/c Mice
J. Virol., April 1, 2009; 83(7): 3323 - 3332.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
N. D. Ulbrandt, H. Ji, N. K. Patel, A. S. Barnes, S. Wilson, P. A. Kiener, J. Suzich, and M. P. McCarthy
Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus
J. Gen. Virol., December 1, 2008; 89(12): 3113 - 3118.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. Mok, S. J. Tollefson, A. B. Podsiad, B. E. Shepherd, V. V. Polosukhin, R. E. Johnston, J. V. Williams, and J. E. Crowe Jr
An Alphavirus Replicon-Based Human Metapneumovirus Vaccine Is Immunogenic and Protective in Mice and Cotton Rats
J. Virol., November 15, 2008; 82(22): 11410 - 11418.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Kolli, E. L. Bataki, L. Spetch, A. Guerrero-Plata, A. M. Jewell, P. A. Piedra, G. N. Milligan, R. P. Garofalo, and A. Casola
T Lymphocytes Contribute to Antiviral Immunity and Pathogenesis in Experimental Human Metapneumovirus Infection
J. Virol., September 1, 2008; 82(17): 8560 - 8569.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Stacy, A. Pasquali, V. L. Sexton, A. M. Cantwell, E. Kraig, and P. H. Dube
An Age-Old Paradigm Challenged: Old Baboons Generate Vigorous Humoral Immune Responses to LcrV, A Plague Antigen
J. Immunol., July 1, 2008; 181(1): 109 - 115.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
M. de Graaf, S. Herfst, E. J. A. Schrauwen, Y. Choi, B. G. van den Hoogen, A. D. M. E. Osterhaus, and R. A. M. Fouchier
Specificity and functional interaction of the polymerase complex proteins of human and avian metapneumoviruses
J. Gen. Virol., April 1, 2008; 89(4): 975 - 983.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
B. G. van den Hoogen, S. Herfst, M. de Graaf, L. Sprong, R. van Lavieren, G. van Amerongen, S. Yuksel, R. A. M. Fouchier, A. D. M. E. Osterhaus, and R. L. de Swart
Experimental infection of macaques with human metapneumovirus induces transient protective immunity
J. Gen. Virol., April 1, 2007; 88(4): 1251 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. D. Ulbrandt, H. Ji, N. K. Patel, J. M. Riggs, Y. A. Brewah, S. Ready, N. E. Donacki, K. Folliot, A. S. Barnes, K. Senthil, et al.
Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.
J. Virol., August 1, 2006; 80(16): 7799 - 7806.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
K. A. Herd, S. Mahalingam, I. M. Mackay, M. Nissen, T. P. Sloots, and R. W. Tindle
Cytotoxic T-Lymphocyte Epitope Vaccination Protects against Human Metapneumovirus Infection and Disease in Mice
J. Virol., February 15, 2006; 80(4): 2034 - 2044.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M.-E. Hamelin, G. A. Prince, and G. Boivin
Effect of Ribavirin and Glucocorticoid Treatment in a Mouse Model of Human Metapneumovirus Infection
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 774 - 777.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Q. N. Pham, S. Biacchesi, M. H. Skiadopoulos, B. R. Murphy, P. L. Collins, and U. J. Buchholz
Chimeric Recombinant Human Metapneumoviruses with the Nucleoprotein or Phosphoprotein Open Reading Frame Replaced by That of Avian Metapneumovirus Exhibit Improved Growth In Vitro and Attenuation In Vivo
J. Virol., December 15, 2005; 79(24): 15114 - 15122.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Biacchesi, Q. N. Pham, M. H. Skiadopoulos, B. R. Murphy, P. L. Collins, and U. J. Buchholz
Infection of Nonhuman Primates with Recombinant Human Metapneumovirus Lacking the SH, G, or M2-2 Protein Categorizes Each as a Nonessential Accessory Protein and Identifies Vaccine Candidates
J. Virol., October 1, 2005; 79(19): 12608 - 12613.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. V. Williams, S. J. Tollefson, J. E. Johnson, and J. E. Crowe Jr.
The Cotton Rat (Sigmodon hispidus) Is a Permissive Small Animal Model of Human Metapneumovirus Infection, Pathogenesis, and Protective Immunity
J. Virol., September 1, 2005; 79(17): 10944 - 10951.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. H. Schickli, J. Kaur, N. Ulbrandt, R. R. Spaete, and R. S. Tang
An S101P Substitution in the Putative Cleavage Motif of the Human Metapneumovirus Fusion Protein Is a Major Determinant for Trypsin-Independent Growth in Vero Cells and Does Not Alter Tissue Tropism in Hamsters
J. Virol., August 15, 2005; 79(16): 10678 - 10689.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M.-E. Hamelin, K. Yim, K. H. Kuhn, R. P. Cragin, M. Boukhvalova, J. C. G. Blanco, G. A. Prince, and G. Boivin
Pathogenesis of Human Metapneumovirus Lung Infection in BALB/c Mice and Cotton Rats
J. Virol., July 15, 2005; 79(14): 8894 - 8903.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
N. Ishiguro, T. Ebihara, R. Endo, X. Ma, R. Shirotsuki, S. Ochiai, H. Ishiko, and H. Kikuta
Immunofluorescence Assay for Detection of Human Metapneumovirus-Specific Antibodies by Use of Baculovirus-Expressed Fusion Protein
Clin. Vaccine Immunol., January 1, 2005; 12(1): 202 - 205.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Alvarez, K. S. Harrod, W.-J. Shieh, S. Zaki, and R. A. Tripp
Human Metapneumovirus Persists in BALB/c Mice despite the Presence of Neutralizing Antibodies
J. Virol., December 15, 2004; 78(24): 14003 - 14011.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Biacchesi, M. H. Skiadopoulos, L. Yang, E. W. Lamirande, K. C. Tran, B. R. Murphy, P. L. Collins, and U. J. Buchholz
Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate
J. Virol., December 1, 2004; 78(23): 12877 - 12887.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. S. Tang, M. MacPhail, J. H. Schickli, J. Kaur, C. L. Robinson, H. A. Lawlor, J. M. Guzzetta, R. R. Spaete, and A. A. Haller
Parainfluenza Virus Type 3 Expressing the Native or Soluble Fusion (F) Protein of Respiratory Syncytial Virus (RSV) Confers Protection from RSV Infection in African Green Monkeys
J. Virol., October 15, 2004; 78(20): 11198 - 11207.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2004 by the Society for General Microbiology.